These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12885102)

  • 21. Drug-induced prolongation of the QT interval: why the regulatory concern?
    Shah RR
    Fundam Clin Pharmacol; 2002 Apr; 16(2):119-24. PubMed ID: 12031064
    [No Abstract]   [Full Text] [Related]  

  • 22. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
    Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
    Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?
    Hondeghem LM
    Drug Saf; 2018 Jan; 41(1):11-17. PubMed ID: 28853038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes.
    Owens RC
    Pharmacotherapy; 2001 Mar; 21(3):301-19. PubMed ID: 11253855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R
    Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk management with regard to QT-prolonging drugs].
    Aengevaeren VL; van Gastel MDA; Fleuren HWHA; Helsloot I; Beukema RJ; Kramers C
    Ned Tijdschr Geneeskd; 2024 Jun; 168():. PubMed ID: 38888230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting drug-induced QT prolongation and torsades de pointes.
    Roden DM
    J Physiol; 2016 May; 594(9):2459-68. PubMed ID: 26660066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.
    Schwartz PJ; Woosley RL
    J Am Coll Cardiol; 2016 Apr; 67(13):1639-1650. PubMed ID: 27150690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.
    Michalets EL; Smith LK; Van Tassel ED
    Ann Pharmacother; 1998; 32(7-8):761-5. PubMed ID: 9681092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of QT prolongation associated with tamoxifen: A review of the literature.
    Fung K; Imeson J; Cusano F
    J Oncol Pharm Pract; 2018 Oct; 24(7):525-530. PubMed ID: 28728494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval.
    Lorberbaum T; Sampson KJ; Woosley RL; Kass RS; Tatonetti NP
    Drug Saf; 2016 May; 39(5):433-41. PubMed ID: 26860921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired QT interval prolongation and HERG: implications for drug discovery and development.
    Finlayson K; Witchel HJ; McCulloch J; Sharkey J
    Eur J Pharmacol; 2004 Oct; 500(1-3):129-42. PubMed ID: 15464027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adverse drug reactions. QT-prolongation and torsade-de-pointes arrhythmias].
    Haffner S; Lapp H; Thürmann PA
    Dtsch Med Wochenschr; 2002 May; 127(19):1022-4. PubMed ID: 11997870
    [No Abstract]   [Full Text] [Related]  

  • 39. Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.
    Khan Q; Ismail M; Khan S
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):75. PubMed ID: 29191244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
    Glassman AH; Bigger JT
    Am J Psychiatry; 2001 Nov; 158(11):1774-82. PubMed ID: 11691681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.